Valuation dashboard for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) with P/E 55.22, P/B 1.58, EV/EBITDA -99.55 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Financial Services companies.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Analysis Summary
Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.
At the current price of $10.84, DMAA trades at a P/E of 55.22 and an ROE of 2.92%. Market capitalisation stands at $263M.
Balance sheet quality for DMAA: current ratio of 0.0. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 55.22 |
| Price / Book | 1.58 |
| EV / EBITDA | -99.55 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| DMAA | Drugs Made In America Acquisition Corp. Ordinary Shares | $263M | 55.22 | 1.58 | 2.9% |
| DCRC | Decarbonization Plus Acquisition Corporation III | $2.3T | 4.73 | -19.3% | |
| RTPY | Reinvent Technology Partners Y | $11.6B | |||
| SSPK | Silver Spike Acquisition Corp. | $3.4B | 942.00 | 33.41 | 3.5% |
| CCXIW | Churchill Capital Corp XI Warrants | $2.1B |
Price
| Price | $10.84 |
| Market Cap | $263M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 2.92% |
| Return on Invested Capital | -1.82% |
| Return on Assets | 4.15% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ALF · LOKV · MLAC · OYSE · RTAC · SIMA · TACH
Explore sector: Financial Services · Shell Companies
More sections of DMAA: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks